Newsletter Subject

Moderna's outrageous and immoral price gouging

From

citizen.org

Email Address

robert@citizen.org

Sent On

Fri, Jan 20, 2023 07:23 PM

Email Preheader Text

Pharmaceutical giant Moderna is threatening to more than quadruple the price of its COVID-19 vaccine

Pharmaceutical giant Moderna is threatening to more than quadruple the price of its COVID-19 vaccine. (Pfizer has already made similar noise.) A few facts: - Development of the vaccine marketed by Moderna was actually done in partnership with the federal government — specifically scientists at the National Institutes of Health (NIH) — and almost entirely funded by American taxpayers, to the tune of some $1.7 billion. - On top of that, the U.S. government has been paying the company an additional $26.36 per dose — for millions and millions of doses — for almost three years now. - As a result, Moderna — a company with just three employees as recently as 2013 — made more than $19 billion in *profits* over just the past two years. - By the way, it costs the company less than $3 per dose to manufacture the vaccine. And — again — research and development was paid for by the American people, not the company. - Yet Moderna’s CEO — a French man named Stéphane Bancel whose personal net worth is estimated at $6.3 billion — wants to jack the price up to as much as $130 per dose. Here’s some of what Sen. Bernie Sanders said in a recent letter to Moderna’s CEO: “The purpose of the recent taxpayer investment in Moderna was to protect the health and lives of the American people, not to turn a handful of corporate executives and investors into multi-billionaires. ... Now is not the time for unacceptable corporate greed.” In reality, the so-called Moderna vaccine belongs to We the People. It is beyond outrageous for the company to even consider jacking up the price. [A message for Moderna CEO Stéphane Bancel:]( [You have already become unimaginably wealthy as a result of the COVID-19 vaccine marketed by your company. As you know full well, the development of that vaccine was funded almost entirely by the American people. Yet you are now planning to more than quadruple the price, which will — not might, will — result in preventable deaths of people who cannot afford your outrageous and immoral price gouging. Dr. Jonas Salk, inventor of the polio vaccine, refused to patent that medication — a choice estimated to have cost him $7 billion. Let that be your guidepost. How much more money could you possibly need, anyway?]( [Click to add your name.]( Thanks for taking action. For progress, - Robert Weissman, President of Public Citizen Public Citizen | 1600 20th Street NW | Washington DC 20009 | [Unsubscribe](

Marketing emails from citizen.org

View More
Sent On

05/12/2024

Sent On

04/12/2024

Sent On

02/12/2024

Sent On

10/11/2024

Sent On

08/11/2024

Sent On

07/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.